Prediction of damage trajectories in systemic sclerosis using group-based trajectory modelling
- PMID: 36625513
- PMCID: PMC10473274
- DOI: 10.1093/rheumatology/kead002
Prediction of damage trajectories in systemic sclerosis using group-based trajectory modelling
Abstract
Objectives: Damage accrual in SSc can be tracked using the Scleroderma Clinical Trials Consortium Damage Index (DI). Our goal was to develop a prediction model for damage accrual in SSc patients with early disease.
Methods: Using patients with <2 years disease duration from Canada and Australia as a derivation cohort, and from the Netherlands as a validation cohort, we used group-based trajectory modelling (GBTM) to determine 'good' and 'bad' latent damage trajectories. We developed a prediction model from this analysis and applied it to patients from derivation and validation cohorts. We plotted the actual DI trajectories of the patients predicted to be in 'good' or 'bad' groups.
Results: We found that the actual trajectories of damage accumulation for lcSSc and dcSSc were very different, so we studied each subset separately. GBTM found two distinct trajectories in lcSSc and three in dcSSc. We collapsed the two worse trajectories in the dcSSc into one group and developed a prediction model for inclusion in either 'good' or 'bad' trajectories. The performance of models using only baseline DI and sex was excellent with ROC AUC of 0.9313 for lcSSc and 0.9027 for dcSSc. Using this model, we determined whether patients would fall into 'good' or 'bad' trajectory groups and then plotted their actual trajectories which showed clear differences between the predicted 'good' and 'bad' cases in both derivation and validation cohorts.
Conclusions: A simple model using only cutaneous subset, baseline DI and sex can predict damage accumulation in early SSc.
Keywords: SSc; damage; mortality; prediction; subset; trajectory; ‘group-based trajectory modelling’.
© The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Figures



References
-
- Ferdowsi N, Huq M, Stevens W. et al. Development and validation of the scleroderma clinical Trials Consortium damage index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis. Ann Rheum Dis 2019;78:807–816. - PubMed
-
- Jones BL, Nagin DS.. Advances in group-based trajectory modeling and an SAS procedure for estimating them. Sociol Methods Res 2007;35:542–571.
-
- Nagin DS, Odgers CL.. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol 2010;6:109–38. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials